SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,093,000 | +16.1% | 26,024 | +0.8% | 0.87% | +11.9% |
| Q2 2020 | $4,386,000 | +44.6% | 25,813 | -1.8% | 0.77% | +23.8% |
| Q1 2020 | $3,034,000 | -0.3% | 26,297 | -1.3% | 0.62% | +24.5% |
| Q4 2019 | $3,043,000 | -2.9% | 26,630 | -27.5% | 0.50% | -2.9% |
| Q3 2019 | $3,135,000 | +21.7% | 36,706 | -1.3% | 0.52% | +21.4% |
| Q2 2019 | $2,575,000 | -6.3% | 37,197 | -0.9% | 0.43% | -10.1% |
| Q1 2019 | $2,748,000 | +32.3% | 37,529 | +2.4% | 0.47% | +18.5% |
| Q4 2018 | $2,077,000 | -29.5% | 36,657 | -4.0% | 0.40% | -19.0% |
| Q3 2018 | $2,946,000 | +14.8% | 38,203 | -1.2% | 0.49% | +11.0% |
| Q2 2018 | $2,567,000 | – | 38,655 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |